Industry News

Mylan Launches Generic Precedex Injection
AstraZeneca says DOJ closes probe into drug trial
FDA-Approved Drug Restores Hair in Patients with Alopecia Areata
B. Braun Receives FDA Approval for Nutrilipid 20% An Intravenous Fat Emulsion Approved for Adult and Pediatric Patients
Philosys Launches GMATE SMART Meter and App - Improving Diabetes Health Gmate SMART connects with iPhone, iPad and iPod touch to deliver accurate and fast blood glucose results
Pfizer Announces Submission of Palbociclib New Drug Application to the FDA
EISAI SUBMITS MARKETING APPROVAL APPLICATIONS FOR ANTICANCER AGENT LENVATINIB SIMULTANEOUSLY IN EUROPE AND U.S.
FDA approves Roche's Avastin plus chemotherapy for treatment of advanced cervical cancer
International Response to West Africa Ebola Epidemic Dangerously Inadequate
Philosys Launches GMATE� SMART Meter and App - Improving Diabetes Health Gmate� SMART connects with iPhone�, iPad� and iPod� touch to deliver accurate and fast blood glucose results
Execution drug cost quadruples for Texas prisons
Genentech Submits Supplemental Biologics License Application to FDA for Lucentis Indication in Diabetic Retinopathy
FDA approves new type of sleep drug, Belsomra
Public Citizen Expert Says FDA Draft Guidance Would Let Pharmaceutical Industry Tell Doctors Medications are Safer than They Really are
23andMe Announces Agreement with Pfizer to Research Genetics of Ulcerative Colitis and Crohn's Disease
B. Braun Receives FDA Approval for Nutrilipid 20% An Intravenous Fat Emulsion Approved for Adult and Pediatric Patients
23andMe Announces Agreement with Pfizer to Research Genetics of Ulcerative Colitis and Crohn's Disease
B. Braun Receives FDA Approval for Nutrilipid� 20% An Intravenous Fat Emulsion Approved for Adult and Pediatric Patients
World Health Organisation allow unlicensed Ebola drugs in west Africa
World Health Organisation allows unlicensed Ebola drugs in west Africa
eAgile Awarded Patent for RFID Intelligent Packaging Breakthrough
Valeant Pharmaceuticals Receives FTC Second Request Under Hart-Scott-Rodino
Valeant Pharmaceuticals Receives FTC Second Request Under Hart-Scott-Rodino
First Varicose Vein Patient Treated with FDA-Approved Varithena (polidocanol injectable foam) 1% Varithena is now available in the US
First Varicose Vein Patient Treated with FDA-Approved Varithena� (polidocanol injectable foam) 1% Varithena� is now available in the US